Explore

Supplier Sourcing

Brands / Suppliers

Verification Marks

Explore

Explore

Companies

MIMETAS

MIMETAS Mimetas develops high-throughput healthy and diseased organ-on-a-chip models in the OrganoPlate®, a screening-compatible microfluidics platform that supports the recreation of native tissue structures, and their interaction with compounds, signaling factors, disease triggers, and co-cultured cell types.

MIMETAS

Netherlands

Mimetas develops high-throughput healthy and diseased organ-on-a-chip models in the OrganoPlate®, a screening-compatible microfluidics platform that supports the recreation of native tissue structures, and their interaction with compounds, signaling factors, disease triggers, and co-cultured cell types.

Biotechnology Research

Overview

Brands / Suppliers

Recent

Recent

A-Z

Z-A

Inquire

1 result

MIMETAS

Unleashing your therapeutic innovation with human 3D disease models. Unmatched disease relevance, precision, throughput and ethical commitment.

OrganoReady®: OrganoReady comprises ready-to-use 3D tissue models for drug exposure, transport, and permeability studies.

Instruments: OrganoPlate® is the solution for all in vitro tissue culture applications. The platform enables unique novel tissue cultures and applications, and is supported by dedicated instruments.

OrganoStart Packages: Start with the most sophisticated 3D tissue culture platform today.

OrganoPlate® is a microfluidic 3D tissue culture plate, supporting up to 96 tissue models on a single plate. Its unique PhaseGuide™ technology enables cells to interact and migrate freely between channels. Work with (co-)cultures in or against an ECM, optimized microenvironments, and perfused tubular tissues without interference of artificial membranes.

(Several) Products

Reached to the end

Products

Sourcing

Buyer

Wishlist

Inquiry